
Helus Pharma to Present at Jefferies Global Healthcare Conference, Highlighting Progress in Novel Serotonergic Agonists
Helus Pharma announced its participation in the Jefferies Global Healthcare Conference, where interim CEO Eric So will discuss the company's clinical-stage development of novel serotonergic agonists for mental health conditions, underscoring the significance of its Phase 3 and Phase 2 programs.
Read full story

























